Allergan beats profit, raises revenue forecast on Restasis, Juvederm demand

Allergan beats profit, raises revenue forecast on Restasis, Juvederm demand

Source: 
Yahoo/Reuters
News Tags: 
snippet: 

Allergan Plc, which is being bought by AbbVie Inc for $63 billion, beat quarterly profit estimates and raised its 2019 revenue forecast on Tuesday, helped by demand for its dry eye drug Restasis and aesthetics product Juvederm.